New insights into glioma frequency maps: From genetic and transcriptomic correlate to survival prediction

Increasing evidence indicates that glioma topographic location is linked to the cellular origin, molecular alterations and genetic profile. This research aims to (a) reveal the underlying mechanisms of tumor location predilection in glioblastoma multiforme (GBM) and lower‐grade glioma (LGG) and (b)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of cancer 2023-03, Vol.152 (5), p.998-1012
Hauptverfasser: Bao, Hongbo, Ren, Peng, Yi, Liye, Lv, Zhonghua, Ding, Wencai, Li, Chenlong, Li, Siyang, Li, Zhipeng, Yang, Xue, Liang, Xia, Liang, Peng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1012
container_issue 5
container_start_page 998
container_title International journal of cancer
container_volume 152
creator Bao, Hongbo
Ren, Peng
Yi, Liye
Lv, Zhonghua
Ding, Wencai
Li, Chenlong
Li, Siyang
Li, Zhipeng
Yang, Xue
Liang, Xia
Liang, Peng
description Increasing evidence indicates that glioma topographic location is linked to the cellular origin, molecular alterations and genetic profile. This research aims to (a) reveal the underlying mechanisms of tumor location predilection in glioblastoma multiforme (GBM) and lower‐grade glioma (LGG) and (b) leverage glioma location features to predict prognosis. MRI images from 396 GBM and 190 LGG (115 astrocytoma and 75 oligodendroglioma) patients were standardized to construct frequency maps and analyzed by voxel‐based lesion‐symptom mapping. We then investigated the spatial correlation between glioma distribution with gene expression in healthy brains. We also evaluated transcriptomic differences in tumor tissue from predilection and nonpredilection sites. Furthermore, we quantitively characterized tumor anatomical localization and explored whether it was significantly related to overall survival. Finally, we employed a support vector machine to build a survival prediction model for GBM patients. GBMs exhibited a distinct location predilection from LGGs. GBMs were nearer to the subventricular zone and more likely to be localized to regions enriched with synaptic signaling, whereas astrocytoma and oligodendroglioma tended to occur in areas associated with the immune response. Synapse, neurotransmitters and calcium ion channel‐related genes were all activated in GBM tissues coming from predilection regions. Furthermore, we characterized tumor location features in terms of a series of tumor‐to‐predilection distance metrics, which were able to predict GBM 1‐year survival status with an accuracy of 0.71. These findings provide new perspectives on our understanding of tumor anatomic localization. The spatial features of glioma are of great value in individual therapy and prognosis prediction. What's new? The spatial distribution of glioma is nonrandom. However, whether pathological grade influences glioma distribution across the brain remains unclear. Here, the authors built a population‐based frequency map for 396 patients with glioblastoma multiforme and 190 patients with lower‐grade glioma, revealing their distinct topographic localization patterns. Further results suggested that neuron and glioma synaptic interactions and electrochemical communications were involved in determining glioblastoma multiforme location, bringing a new perspective on glioma location predilection and gliomagenesis. Moreover, based on the identified tumor location features, the authors bui
doi_str_mv 10.1002/ijc.34336
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10100131</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2760446075</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4446-c2ba17d4a5f0d00634bb26bd04af18bfb730b89e2942908f17fe6921202d10da3</originalsourceid><addsrcrecordid>eNp1kcFu1DAURa0KRIfCoj-ALLGBRdr3bMeZdIPQiJaiqt3QteU4ztSjxA52MtX8PabTVlCJlS376Oi-dwk5RjhBAHbqNuaEC87lAVkg1FUBDMtXZJH_oKiQy0PyNqUNAGIJ4g055JJDKUW9IO7a3lPnk1vfTSlfpkDXvQuDpl20v2brzY4Oekxn9DyGga6tt5MzVPuWTlH7ZKIbpzDkJxNitL2eLM2ONMet2-qejtG2zkwu-Hfkdaf7ZN8_nkfk9vzbz9X34urm4nL19aowQghZGNZorFqhyw5aAMlF0zDZtCB0h8umayoOzbK2rBashmWHVWdlzZABaxFazY_Il713nJvBtsb6HLRXY3SDjjsVtFP__nh3p9ZhqxDyMpFjNnx6NMSQV5AmNbhkbN9rb8OcFMsRONa8khn9-ALdhDn6PF-mJOSBoCoz9XlPmRhSirZ7ToOg_jSocoPqocHMfvg7_jP5VFkGTvfAvevt7v8mdfljtVf-BvNWpsI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2760446075</pqid></control><display><type>article</type><title>New insights into glioma frequency maps: From genetic and transcriptomic correlate to survival prediction</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Online Library All Journals</source><creator>Bao, Hongbo ; Ren, Peng ; Yi, Liye ; Lv, Zhonghua ; Ding, Wencai ; Li, Chenlong ; Li, Siyang ; Li, Zhipeng ; Yang, Xue ; Liang, Xia ; Liang, Peng</creator><creatorcontrib>Bao, Hongbo ; Ren, Peng ; Yi, Liye ; Lv, Zhonghua ; Ding, Wencai ; Li, Chenlong ; Li, Siyang ; Li, Zhipeng ; Yang, Xue ; Liang, Xia ; Liang, Peng</creatorcontrib><description>Increasing evidence indicates that glioma topographic location is linked to the cellular origin, molecular alterations and genetic profile. This research aims to (a) reveal the underlying mechanisms of tumor location predilection in glioblastoma multiforme (GBM) and lower‐grade glioma (LGG) and (b) leverage glioma location features to predict prognosis. MRI images from 396 GBM and 190 LGG (115 astrocytoma and 75 oligodendroglioma) patients were standardized to construct frequency maps and analyzed by voxel‐based lesion‐symptom mapping. We then investigated the spatial correlation between glioma distribution with gene expression in healthy brains. We also evaluated transcriptomic differences in tumor tissue from predilection and nonpredilection sites. Furthermore, we quantitively characterized tumor anatomical localization and explored whether it was significantly related to overall survival. Finally, we employed a support vector machine to build a survival prediction model for GBM patients. GBMs exhibited a distinct location predilection from LGGs. GBMs were nearer to the subventricular zone and more likely to be localized to regions enriched with synaptic signaling, whereas astrocytoma and oligodendroglioma tended to occur in areas associated with the immune response. Synapse, neurotransmitters and calcium ion channel‐related genes were all activated in GBM tissues coming from predilection regions. Furthermore, we characterized tumor location features in terms of a series of tumor‐to‐predilection distance metrics, which were able to predict GBM 1‐year survival status with an accuracy of 0.71. These findings provide new perspectives on our understanding of tumor anatomic localization. The spatial features of glioma are of great value in individual therapy and prognosis prediction. What's new? The spatial distribution of glioma is nonrandom. However, whether pathological grade influences glioma distribution across the brain remains unclear. Here, the authors built a population‐based frequency map for 396 patients with glioblastoma multiforme and 190 patients with lower‐grade glioma, revealing their distinct topographic localization patterns. Further results suggested that neuron and glioma synaptic interactions and electrochemical communications were involved in determining glioblastoma multiforme location, bringing a new perspective on glioma location predilection and gliomagenesis. Moreover, based on the identified tumor location features, the authors built a survival prediction model for patients with glioblastoma multiforme.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/ijc.34336</identifier><identifier>PMID: 36305649</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Astrocytoma ; Brain cancer ; Brain Neoplasms - pathology ; Brain tumors ; Cancer ; frequency map ; GBM ; Gene expression ; Gene mapping ; Glioblastoma ; Glioblastoma - pathology ; Glioma ; Glioma - pathology ; Humans ; Immune response ; LGG ; Localization ; Medical prognosis ; Medical research ; Neurotransmitters ; Oligodendroglioma ; Oligodendroglioma - genetics ; Prediction models ; Prognosis ; Subventricular zone ; survival prediction ; synapse ; Transcriptome ; Transcriptomics ; Tumor Immunology and Microenvironment</subject><ispartof>International journal of cancer, 2023-03, Vol.152 (5), p.998-1012</ispartof><rights>2022 The Authors. published by John Wiley &amp; Sons Ltd on behalf of UICC.</rights><rights>2022 The Authors. International Journal of Cancer published by John Wiley &amp; Sons Ltd on behalf of UICC.</rights><rights>2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4446-c2ba17d4a5f0d00634bb26bd04af18bfb730b89e2942908f17fe6921202d10da3</citedby><cites>FETCH-LOGICAL-c4446-c2ba17d4a5f0d00634bb26bd04af18bfb730b89e2942908f17fe6921202d10da3</cites><orcidid>0000-0003-1043-6951 ; 0000-0002-9394-5016</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fijc.34336$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fijc.34336$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,315,782,786,887,1419,27931,27932,45581,45582</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36305649$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bao, Hongbo</creatorcontrib><creatorcontrib>Ren, Peng</creatorcontrib><creatorcontrib>Yi, Liye</creatorcontrib><creatorcontrib>Lv, Zhonghua</creatorcontrib><creatorcontrib>Ding, Wencai</creatorcontrib><creatorcontrib>Li, Chenlong</creatorcontrib><creatorcontrib>Li, Siyang</creatorcontrib><creatorcontrib>Li, Zhipeng</creatorcontrib><creatorcontrib>Yang, Xue</creatorcontrib><creatorcontrib>Liang, Xia</creatorcontrib><creatorcontrib>Liang, Peng</creatorcontrib><title>New insights into glioma frequency maps: From genetic and transcriptomic correlate to survival prediction</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>Increasing evidence indicates that glioma topographic location is linked to the cellular origin, molecular alterations and genetic profile. This research aims to (a) reveal the underlying mechanisms of tumor location predilection in glioblastoma multiforme (GBM) and lower‐grade glioma (LGG) and (b) leverage glioma location features to predict prognosis. MRI images from 396 GBM and 190 LGG (115 astrocytoma and 75 oligodendroglioma) patients were standardized to construct frequency maps and analyzed by voxel‐based lesion‐symptom mapping. We then investigated the spatial correlation between glioma distribution with gene expression in healthy brains. We also evaluated transcriptomic differences in tumor tissue from predilection and nonpredilection sites. Furthermore, we quantitively characterized tumor anatomical localization and explored whether it was significantly related to overall survival. Finally, we employed a support vector machine to build a survival prediction model for GBM patients. GBMs exhibited a distinct location predilection from LGGs. GBMs were nearer to the subventricular zone and more likely to be localized to regions enriched with synaptic signaling, whereas astrocytoma and oligodendroglioma tended to occur in areas associated with the immune response. Synapse, neurotransmitters and calcium ion channel‐related genes were all activated in GBM tissues coming from predilection regions. Furthermore, we characterized tumor location features in terms of a series of tumor‐to‐predilection distance metrics, which were able to predict GBM 1‐year survival status with an accuracy of 0.71. These findings provide new perspectives on our understanding of tumor anatomic localization. The spatial features of glioma are of great value in individual therapy and prognosis prediction. What's new? The spatial distribution of glioma is nonrandom. However, whether pathological grade influences glioma distribution across the brain remains unclear. Here, the authors built a population‐based frequency map for 396 patients with glioblastoma multiforme and 190 patients with lower‐grade glioma, revealing their distinct topographic localization patterns. Further results suggested that neuron and glioma synaptic interactions and electrochemical communications were involved in determining glioblastoma multiforme location, bringing a new perspective on glioma location predilection and gliomagenesis. Moreover, based on the identified tumor location features, the authors built a survival prediction model for patients with glioblastoma multiforme.</description><subject>Astrocytoma</subject><subject>Brain cancer</subject><subject>Brain Neoplasms - pathology</subject><subject>Brain tumors</subject><subject>Cancer</subject><subject>frequency map</subject><subject>GBM</subject><subject>Gene expression</subject><subject>Gene mapping</subject><subject>Glioblastoma</subject><subject>Glioblastoma - pathology</subject><subject>Glioma</subject><subject>Glioma - pathology</subject><subject>Humans</subject><subject>Immune response</subject><subject>LGG</subject><subject>Localization</subject><subject>Medical prognosis</subject><subject>Medical research</subject><subject>Neurotransmitters</subject><subject>Oligodendroglioma</subject><subject>Oligodendroglioma - genetics</subject><subject>Prediction models</subject><subject>Prognosis</subject><subject>Subventricular zone</subject><subject>survival prediction</subject><subject>synapse</subject><subject>Transcriptome</subject><subject>Transcriptomics</subject><subject>Tumor Immunology and Microenvironment</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><recordid>eNp1kcFu1DAURa0KRIfCoj-ALLGBRdr3bMeZdIPQiJaiqt3QteU4ztSjxA52MtX8PabTVlCJlS376Oi-dwk5RjhBAHbqNuaEC87lAVkg1FUBDMtXZJH_oKiQy0PyNqUNAGIJ4g055JJDKUW9IO7a3lPnk1vfTSlfpkDXvQuDpl20v2brzY4Oekxn9DyGga6tt5MzVPuWTlH7ZKIbpzDkJxNitL2eLM2ONMet2-qejtG2zkwu-Hfkdaf7ZN8_nkfk9vzbz9X34urm4nL19aowQghZGNZorFqhyw5aAMlF0zDZtCB0h8umayoOzbK2rBashmWHVWdlzZABaxFazY_Il713nJvBtsb6HLRXY3SDjjsVtFP__nh3p9ZhqxDyMpFjNnx6NMSQV5AmNbhkbN9rb8OcFMsRONa8khn9-ALdhDn6PF-mJOSBoCoz9XlPmRhSirZ7ToOg_jSocoPqocHMfvg7_jP5VFkGTvfAvevt7v8mdfljtVf-BvNWpsI</recordid><startdate>20230301</startdate><enddate>20230301</enddate><creator>Bao, Hongbo</creator><creator>Ren, Peng</creator><creator>Yi, Liye</creator><creator>Lv, Zhonghua</creator><creator>Ding, Wencai</creator><creator>Li, Chenlong</creator><creator>Li, Siyang</creator><creator>Li, Zhipeng</creator><creator>Yang, Xue</creator><creator>Liang, Xia</creator><creator>Liang, Peng</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1043-6951</orcidid><orcidid>https://orcid.org/0000-0002-9394-5016</orcidid></search><sort><creationdate>20230301</creationdate><title>New insights into glioma frequency maps: From genetic and transcriptomic correlate to survival prediction</title><author>Bao, Hongbo ; Ren, Peng ; Yi, Liye ; Lv, Zhonghua ; Ding, Wencai ; Li, Chenlong ; Li, Siyang ; Li, Zhipeng ; Yang, Xue ; Liang, Xia ; Liang, Peng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4446-c2ba17d4a5f0d00634bb26bd04af18bfb730b89e2942908f17fe6921202d10da3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Astrocytoma</topic><topic>Brain cancer</topic><topic>Brain Neoplasms - pathology</topic><topic>Brain tumors</topic><topic>Cancer</topic><topic>frequency map</topic><topic>GBM</topic><topic>Gene expression</topic><topic>Gene mapping</topic><topic>Glioblastoma</topic><topic>Glioblastoma - pathology</topic><topic>Glioma</topic><topic>Glioma - pathology</topic><topic>Humans</topic><topic>Immune response</topic><topic>LGG</topic><topic>Localization</topic><topic>Medical prognosis</topic><topic>Medical research</topic><topic>Neurotransmitters</topic><topic>Oligodendroglioma</topic><topic>Oligodendroglioma - genetics</topic><topic>Prediction models</topic><topic>Prognosis</topic><topic>Subventricular zone</topic><topic>survival prediction</topic><topic>synapse</topic><topic>Transcriptome</topic><topic>Transcriptomics</topic><topic>Tumor Immunology and Microenvironment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bao, Hongbo</creatorcontrib><creatorcontrib>Ren, Peng</creatorcontrib><creatorcontrib>Yi, Liye</creatorcontrib><creatorcontrib>Lv, Zhonghua</creatorcontrib><creatorcontrib>Ding, Wencai</creatorcontrib><creatorcontrib>Li, Chenlong</creatorcontrib><creatorcontrib>Li, Siyang</creatorcontrib><creatorcontrib>Li, Zhipeng</creatorcontrib><creatorcontrib>Yang, Xue</creatorcontrib><creatorcontrib>Liang, Xia</creatorcontrib><creatorcontrib>Liang, Peng</creatorcontrib><collection>Wiley-Blackwell Open Access Titles</collection><collection>Wiley Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bao, Hongbo</au><au>Ren, Peng</au><au>Yi, Liye</au><au>Lv, Zhonghua</au><au>Ding, Wencai</au><au>Li, Chenlong</au><au>Li, Siyang</au><au>Li, Zhipeng</au><au>Yang, Xue</au><au>Liang, Xia</au><au>Liang, Peng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>New insights into glioma frequency maps: From genetic and transcriptomic correlate to survival prediction</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>2023-03-01</date><risdate>2023</risdate><volume>152</volume><issue>5</issue><spage>998</spage><epage>1012</epage><pages>998-1012</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><abstract>Increasing evidence indicates that glioma topographic location is linked to the cellular origin, molecular alterations and genetic profile. This research aims to (a) reveal the underlying mechanisms of tumor location predilection in glioblastoma multiforme (GBM) and lower‐grade glioma (LGG) and (b) leverage glioma location features to predict prognosis. MRI images from 396 GBM and 190 LGG (115 astrocytoma and 75 oligodendroglioma) patients were standardized to construct frequency maps and analyzed by voxel‐based lesion‐symptom mapping. We then investigated the spatial correlation between glioma distribution with gene expression in healthy brains. We also evaluated transcriptomic differences in tumor tissue from predilection and nonpredilection sites. Furthermore, we quantitively characterized tumor anatomical localization and explored whether it was significantly related to overall survival. Finally, we employed a support vector machine to build a survival prediction model for GBM patients. GBMs exhibited a distinct location predilection from LGGs. GBMs were nearer to the subventricular zone and more likely to be localized to regions enriched with synaptic signaling, whereas astrocytoma and oligodendroglioma tended to occur in areas associated with the immune response. Synapse, neurotransmitters and calcium ion channel‐related genes were all activated in GBM tissues coming from predilection regions. Furthermore, we characterized tumor location features in terms of a series of tumor‐to‐predilection distance metrics, which were able to predict GBM 1‐year survival status with an accuracy of 0.71. These findings provide new perspectives on our understanding of tumor anatomic localization. The spatial features of glioma are of great value in individual therapy and prognosis prediction. What's new? The spatial distribution of glioma is nonrandom. However, whether pathological grade influences glioma distribution across the brain remains unclear. Here, the authors built a population‐based frequency map for 396 patients with glioblastoma multiforme and 190 patients with lower‐grade glioma, revealing their distinct topographic localization patterns. Further results suggested that neuron and glioma synaptic interactions and electrochemical communications were involved in determining glioblastoma multiforme location, bringing a new perspective on glioma location predilection and gliomagenesis. Moreover, based on the identified tumor location features, the authors built a survival prediction model for patients with glioblastoma multiforme.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>36305649</pmid><doi>10.1002/ijc.34336</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0003-1043-6951</orcidid><orcidid>https://orcid.org/0000-0002-9394-5016</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0020-7136
ispartof International journal of cancer, 2023-03, Vol.152 (5), p.998-1012
issn 0020-7136
1097-0215
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10100131
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Online Library All Journals
subjects Astrocytoma
Brain cancer
Brain Neoplasms - pathology
Brain tumors
Cancer
frequency map
GBM
Gene expression
Gene mapping
Glioblastoma
Glioblastoma - pathology
Glioma
Glioma - pathology
Humans
Immune response
LGG
Localization
Medical prognosis
Medical research
Neurotransmitters
Oligodendroglioma
Oligodendroglioma - genetics
Prediction models
Prognosis
Subventricular zone
survival prediction
synapse
Transcriptome
Transcriptomics
Tumor Immunology and Microenvironment
title New insights into glioma frequency maps: From genetic and transcriptomic correlate to survival prediction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T23%3A42%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=New%20insights%20into%20glioma%20frequency%20maps:%20From%20genetic%20and%20transcriptomic%20correlate%20to%20survival%20prediction&rft.jtitle=International%20journal%20of%20cancer&rft.au=Bao,%20Hongbo&rft.date=2023-03-01&rft.volume=152&rft.issue=5&rft.spage=998&rft.epage=1012&rft.pages=998-1012&rft.issn=0020-7136&rft.eissn=1097-0215&rft_id=info:doi/10.1002/ijc.34336&rft_dat=%3Cproquest_pubme%3E2760446075%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2760446075&rft_id=info:pmid/36305649&rfr_iscdi=true